Rearrangement of the transmembrane domain interfaces associated with the activation of a GPCR hetero-oligomer

Xue Li, Qian Sun, Han Zhao, Xavier Rovira, Siyu Gai, Qianwen He, Jean‐Philippe Pin, Jianfeng Liu, Philippe RondardNature Communications 2019 · DOI

Abstract: G protein-coupled receptors (GPCRs) can integrate extracellular signals via allosteric interactions within dimers and higher-order oligomers. However, the structural bases of these interactions remain unclear. Here, we use the $\text{GABA}_B$ receptor heterodimer as a model as it forms large complexes in the brain. It is subjected to genetic mutations mainly affecting transmembrane 6 (TM6) and involved in human diseases. By cross-linking, we identify the transmembrane interfaces involved in $\text{GABA}_{B1}$-$\text{GABA}_{B2}$, as well as $\text{GABA}_{B1}$-$\text{GABA}_{B1}$ interactions. Our data are consistent with an oligomer made of a row of $\text{GABA}_{B1}$. We bring evidence that agonist activation induces a concerted rearrangement of the various interfaces. While the GB1-GB2 interface is proposed to involve TM5 in the inactive state, cross-linking of TM6s lead to constitutive activity. These data bring insight for our understanding of the allosteric interaction between GPCRs within oligomers.

The Mystery of GPCR Oligomerization

G protein-coupled receptors (GPCRs) are the primary gatekeepers of cellular communication, serving as targets for approximately one-third of all FDA-approved drugs. While traditionally viewed as monomeric units, it is now understood that many GPCRs function as dimers or higher-order oligomers. The $\text{GABA}_B$ receptor is a prototypical model for this complexity; it is a mandatory heterodimer composed of two subunits: GB1, which contains the orthosteric binding site for the neurotransmitter GABA, and GB2, which is responsible for activating internal G-proteins.

Schematic representation of the $\text{GABA}_B$ receptor heterodimer, showing the extracellular domains (ECD) and the seven-transmembrane (7TM) domains.

While high-resolution structures of the extracellular domains (ECDs) have been available, the structural dynamics of the seven-transmembrane (7TM) helices during activation remained elusive. Understanding how these "legs" of the receptor rearrange is crucial for deciphering how extracellular signals are transduced across the membrane and how multiple dimers coordinate their activity in the crowded environment of the brain.

Mapping the Transmembrane "Dance"

To investigate these dynamics, researchers employed a site-specific cysteine cross-linking approach. By systematically introducing cysteine residues along the transmembrane helices of both GB1 and GB2, they could "staple" the subunits together using oxidative cross-linking with a copper complex (CuP). If two cysteines are within approximately 8 Å, they form a disulfide bridge, allowing the researchers to identify which helices are in close proximity during different functional states.

The study revealed a dramatic "interface switch" during activation. In the inactive, resting state, the GB1 and GB2 subunits primarily interact via transmembrane helix 5 (TM5). However, upon the addition of an agonist (GABA), the 7TM domains undergo a concerted rearrangement, shifting the primary interface to transmembrane helix 6 (TM6). This TM5-to-TM6 transition appears to be a hallmark of the receptor's transition from an "off" to an "on" state.

From Dimers to Linear Rows

Beyond the individual heterodimer, the study explored how $\text{GABA}_B$ receptors organize into larger complexes. The cross-linking data suggests that these receptors do not float randomly but rather assemble into linear oligomeric rows.

Structural models illustrating (a) the basic heterodimer, (b) the proposed higher-order oligomer organized in rows, and (c) the location of genetic mutations associated with epileptic encephalopathy and Rett-like syndrome.

Interestingly, these rows are maintained by specific GB1-GB1 interactions involving TM4 and TM6, while the GB2 subunits are positioned on the periphery. This arrangement may optimize the receptor's ability to interact with G-proteins, as the GB2 subunits remain accessible for signaling even within a large cluster.

Structural Basis of Neurological Disorders

The research also sheds light on the molecular mechanisms underlying severe neurological conditions. The authors examined several genetic mutations in the GB2 subunit, such as S695I and A707T, which are associated with epileptic encephalopathy and Rett-like syndrome, respectively.

Functional assays and molecular modeling indicated that these mutations occur at the TM6 interface. Crucially, these mutations appear to stabilize the "active" TM6-TM6 configuration, leading to constitutive activity—where the receptor remains signaling even in the absence of GABA. This constant "on" state likely disrupts the delicate balance of inhibitory signaling in the brain, contributing to the clinical phenotypes observed in patients.

Conclusion and Future Directions

By mapping the dynamic interfaces of the $\text{GABA}_B$ receptor, this study provides a structural framework for understanding GPCR allostery within oligomers. The discovery of the TM5-to-TM6 switch and the linear row organization offers new targets for drug development. Rather than focusing solely on traditional binding pockets, future "allosteric" drugs could be designed to stabilize or disrupt specific transmembrane interfaces, providing a more nuanced way to fine-tune receptor activity in the treatment of neurological and psychiatric disorders.

Summary updated

Abstract

G protein-coupled receptors (GPCRs) can integrate extracellular signals via allosteric interactions within dimers and higher-order oligomers. However, the structural bases of these interactions remain unclear. Here, we use the GABA<sub>B</sub> receptor heterodimer as a model as it forms large complexes in the brain. It is subjected to genetic mutations mainly affecting transmembrane 6 (TM6) and involved in human diseases. By cross-linking, we identify the transmembrane interfaces involved in GABA<sub>B1</sub>-GABA<sub>B2</sub>, as well as GABA<sub>B1</sub>-GABA<sub>B1</sub> interactions. Our data are consistent with an oligomer made of a row of GABA<sub>B1</sub>. We bring evidence that agonist activation induces a concerted rearrangement of the various interfaces. While the GB1-GB2 interface is proposed to involve TM5 in the inactive state, cross-linking of TM6s lead to constitutive activity. These data bring insight for our understanding of the allosteric interaction between GPCRs within oligomers.
BibTeX
@inproceedings{li2019rearrangement,
  author = {Xue Li and Qian Sun and Han Zhao and Xavier Rovira and Siyu Gai and Qianwen He and Jean‐Philippe Pin and Jianfeng Liu and Philippe Rondard},
  title = {{Rearrangement of the transmembrane domain interfaces associated with the activation of a GPCR hetero-oligomer}},
  booktitle = {Nature Communications},
  year = {2019},
  doi = {10.1038/s41467-019-10834-5},
}
Figure